MORTALITY PREDICTION IN PATIENTS WITH HBV-RELATED HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Ji, Dong [1 ]
Chen, Song-Hai [2 ]
Wang, Yu-Dong [3 ]
Lu, Yiying [2 ]
Chen, Guofeng [2 ]
Lau, George [3 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Senior Dept Hepatol, Med Ctr 5, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Liver Dis, Med Ctr 5, Beijing, Peoples R China
[3] Human & Hlth Med Grp, Beijing, Peoples R China
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
719
引用
收藏
页码：439A / 439A
页数：1
相关论文
共 50 条
  • [31] Prospective analysis of risk factors for hepatocellular carcinoma in patients with HBV-related liver cirrhosis
    Shang, Hongyan
    Liu, Can
    Wu, Wennan
    Huang, Jinlan
    Lin, Jinpiao
    Chen, Tianbin
    Xun, Zhen
    Ou, Qishui
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (11): : 13108 - 13116
  • [32] Prognostic value of integrin variants and expression in postoperative patients with HBV-related hepatocellular carcinoma
    Shang, Liming
    Ye, Xinping
    Zhu, Guangzhi
    Su, Hao
    Su, Zhixiong
    Chen, Bin
    Xiao, Kaiyin
    Li, Lequn
    Peng, Minhao
    Peng, Tao
    [J]. ONCOTARGET, 2017, 8 (44) : 76816 - 76831
  • [33] Nucleoside analogs treatment delay the onset of hepatocellular carcinoma in patients with HBV-related cirrhosis
    Bi, Jingfeng
    Zhan, Zheng
    Qin, Enqiang
    Hou, Jun
    Liu, Shuiwen
    Liu, Zengmin
    Li, Shuo
    Wei, Zhenman
    Zhong, Yanwei
    [J]. ONCOTARGET, 2017, 8 (57) : 96725 - 96731
  • [34] CLINICAL RELEVANCE OF INTRAHEPATIC HBV ACTIVITY IN OVERT AND OCCULT HBV-RELATED HEPATOCELLULAR CARCINOMA
    Lee, I-Cheng
    Huang, Chen-Che
    Hou, Ming-Chih
    Huang, Yi Hsiang
    [J]. HEPATOLOGY, 2022, 76 : S317 - S317
  • [35] Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
    Huihui Lu
    Wei Yi
    Fangfang Sun
    Zhan Zeng
    Lu Zhang
    Minghui Li
    Yao Xie
    [J]. 生物安全与健康(英文), 2021, 03 (04) : 190 - 196
  • [36] Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma
    Li, Chuan
    Li, Zhi-Cheng
    Ma, Liang
    Li, Le-Qun
    Zhong, Jian-Hong
    Xiang, Bang-De
    Gong, Wen-Feng
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (08) : 749 - 756
  • [37] Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
    Lu, Huihui
    Yi, Wei
    Sun, Fangfang
    Zeng, Zhan
    Zhang, Lu
    Li, Minghui
    Xie, Yao
    [J]. BIOSAFETY AND HEALTH, 2021, 3 (04) : 190 - 196
  • [38] The diagnostic and prognostic implications of PRKRA expression in HBV-related hepatocellular carcinoma
    Yi-Min Hu
    Ruoxi Ran
    Chaoqi Yang
    Song-Mei Liu
    [J]. Infectious Agents and Cancer, 17
  • [39] HBV-related hepatocellular carcinoma: A call to improve surveillance and linkage to care
    Huang, Daniel Q.
    Hoang, Joseph K.
    Nguyen, Mindie H.
    [J]. LIVER INTERNATIONAL, 2021, 41 (09) : 2238 - 2239
  • [40] Serum/Plasma MicroRNAs as Biomarkers for HBV-Related Hepatocellular Carcinoma in China
    Yin, Wen
    Zhao, Yan
    Ji, Yong-Jing
    Tong, Li-Ping
    Liu, Ya
    He, Shui-Xiang
    Wang, Ai-Qin
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
12345